Special Opportunities Fund Declares Distributions For

NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) — Special Opportunities Fund, Inc. (NYSE: SPE) (the “Fund”) has announced that the Fund’s Board of Directors (the “Board”) has declared the next three monthly distributions under the Fund’s managed distribution plan. Under the Fund’s managed distribution plan, the Fund intends to make monthly distributions to common stockholders … Read more

We Can Stop Teen Suicide

I have a patient named “Alex.” He is 15. He feels alone, down almost every day. He tells me he’s having trouble with schoolwork. He worries about his future. He struggles to make friends and keep the ones he has. He says it’s hard to get out of bed, to shower and brush his teeth. … Read more

Mulvihill Enhanced Split Preferred Share ETF Declares

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) — (TSX: SPFD) Mulvihill Enhanced Split Preferred Share ETF has declared a monthly cash distribution in the amount of $0.08333 per unit, payable on November 7, 2025 to unitholders of record on October 31, 2025. For further information, please contact Investor Relations at 416.681.3966, toll free at 1.800.725.7172, email … Read more

Mary Roach’s New Book Replaceable You Explores Challenges in Replacing Body Parts

Rachel Feltman: For Scientific American’s Science Quickly, I’m Rachel Feltman. Humans have been trying to replace ailing parts of our bodies for thousands of years, turning to prosthetic limbs, regrown noses, you name it. But creating something that works as well as our original equipment remains an enormous challenge. Here to walk us through the … Read more

Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) — (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF has declared a monthly cash distribution in the amount of $0.058333 per unit, payable on November 7, 2025 to unitholders of record on October 31, 2025. For further information, please contact Investor Relations at 416.681.3966, toll free at 1.800.725.7172, email … Read more

What Is Leucovorin, the Unproven Autism Drug Backed by Trump Officials?

According to Martin Makary, head of the US Food and Drug Administration (FDA), the drug leucovorin will help “hundreds of thousands of kids” with autism. But a day after Makary praised leucovorin’s powers at a White House event, some specialists are warning that the science to warrant Makary’s enthusiasm is far from solid. Those researchers … Read more

‘Nightmare Bacteria’ Infections Spiking, Leaving Key Carbapenem Antibiotics Useless, CDC Warns

September 24, 2025 3 min read Infections of Drug-Resistant ‘Nightmare Bacteria’ Are Surging in Hospitals The infection rate of one type of carbapenem-resistant Enterobacterales bacteria has risen by more than 460 percent in recent years. Scientists say people receiving treatment in hospitals are at highest risk By Lauren J. Young edited by Tanya Lewis Microbiologist … Read more